Potential inhibitors of the interaction between ACE2 and SARS-CoV-2 (RBD), to develop a drug

Clinical Characteristics of Coronavirus Disease 2019 in China

Wei‐jie Guan, Zhengyi Ni, Yu Hu et al. · New England Journal of Medicine · 2020 · 31.2K citations · Full text

Veterinary Medicine, Infectious Diseases, Internal Medicine +10

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Markus Hoffmann, Hannah Kleine‐Weber, Simon Schroeder et al. · Cell · 2020 · 21.4K citations · Full text

Life Sciences, Cell Biology, Molecular Biology +11

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

Roujian Lu, Xiang Zhao, Juan Li et al. · The Lancet · 2020 · 12.6K citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +14

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Daniel Wrapp, Nianshuang Wang, Kizzmekia S. Corbett et al. · Science · 2020 · 9.8K citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

Alexandra C. Walls, Young‐Jun Park, M. Alejandra Tortorici et al. · Cell · 2020 · 9.1K citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +10